DIN 02245531 — ARIXTRA 2.5 MG
ARIXTRA is a solution of Fondaparinux marketed by ASPEN PHARMACARE CANADA INC.. The full Fondaparinux monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02245531
- Brand name
- ARIXTRA
- Active ingredient
- Fondaparinux
- Strength
- 2.5 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- ASPEN PHARMACARE CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Synthetic pentasaccharide anticoagulant (Factor Xa inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fondaparinux products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02451719 | ARIXTRA | 10 MG | SOLUTION | ASPEN PHARMACARE CANADA INC. | DORMANT |
| 02451700 | ARIXTRA | 5 MG | SOLUTION | ASPEN PHARMACARE CANADA INC. | DORMANT |
| 02258056 | ARIXTRA | 7.5 MG | SOLUTION | ASPEN PHARMACARE CANADA INC. | MARKETED |
| 02406853 | FONDAPARINUX SODIUM INJECTION | 2.5 MG | SOLUTION | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02406896 | FONDAPARINUX SODIUM INJECTION | 7.5 MG | SOLUTION | DR REDDY'S LABORATORIES LTD | MARKETED |